
               
               
               7 DRUG INTERACTIONS
               
                  No formal drug interaction studies have been conducted. 
                  See 
                        WARNINGS AND PRECAUTIONS: Bleeding Episodes (5.3)
                      for information regarding simultaneous administration of CEPROTIN and tissue plasminogen activator (tPA).
                  See 
                        DOSAGE AND ADMINISTRATION: Initiation of Vitamin K Antagonists (2.3)
                      for information regarding use of CEPROTIN and vitamin K antagonists.
               
               
               
                  
                     
                        
                           None known. (7)
                           
                        
                     
                  
               
            
         